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http:WHAT THIS PAPER ADDS
In this retrospective report, we described our 42 patients undergoing the chimney technique for juxtarenal
aortic aneurysms (JRAAs). Present our technical aspects of this procedure, our satisfactory results, and some
acceptable complications. Compare to other previous reports, our study has larger population and longer
duration of follow-up. Our study demonstrates that in the clinical practice, you can treat JRAAs with this cheaper
and immediately available technique.Objective: Chimney endovascular aneurysm repair (Ch-EVAR) is a cheap and immediately available method for
treatment of juxtarenal aortic aneurysms (JRAAs). The aim of this study was to report experiences and results
with balloon expandable stent (BES) for Ch-EVAR.
Methods: From January 2008 to June 2013 (mean time, 26  13 months), 42 patients who underwent Ch-EVAR
were retrospectively reviewed. All patients were thought to be at high risk for open surgery and were unsuitable
(because of ﬁnancial issues and fear of delays) for fenestrated endovascular aneurysm repair (FEVAR).
Results: 42 patients (35 males; mean age 71  7 years) underwent chimney procedures for 56 renal arteries with
70 BESs (59 hippocampus and 11 genesis). Median follow up was 26 months (range 6e64 months). Primary
technical success was 100%. Thirty day mortality was 0%. Completion angiography showed that eight cases (19%)
had a type I endoleak. The 6 month follow up CT scans demonstrated three cases with complete regression of
endoleak, two cases without aneurysmal growth, and three cases with an increase in aneurysmal diameter of less
than 10 mm. Three patients had contrast induced nephropathy (CIN) after Ch-EVAR, two of whom had acute
renal failure (ARF) and continue to require hemodialysis. Two deaths occurred during follow up, both unrelated
to the aorta: one with a hemispheric stroke at 6 months and one with respiratory failure at 12 months. Therefore,
the overall follow up mortality was 5%. Occlusion of one chimney stent occurred 3 months after the procedure,
meaning renal artery patency rate was 98%. The aneurysm diameter reduced from 74  9 mm to 64  10 mm
during follow up (p < .05).
Conclusion: Ch-EVAR can be used to treat JRAAs with suitable anatomical conditions. However, complications of
type I endoleak were not uncommon, and, therefore, further studies are required to prove its efﬁciency for
JRAAs.
 2014 Published by Elsevier Ltd on behalf of European Society for Vascular Surgery.
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Conventional endovascular aortic repair (EVAR) is not suit-
able for juxtarenal aortic aneurysms (JRAAs) with inadequate
proximal landing zone. Alternative endovascular treatment
options for JRAAs include chimney endovascular aneurysm
repair (Ch-EVAR), fenestrated endovascular aneurysm repair
(FEVAR), and multiple branched stent graft.1,2Xiaohui and Hu ZhongZhou are co-ﬁrst authors.
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//dx.doi.org/10.1016/j.ejvs.2014.11.012Ch-EVAR involves concurrent deployment of a standard
aortic endograft associated with typical stent grafts in the
target arteries, and thus it has the advantages of being
immediately available and cheaper than FEVAR.3,4 In this
study, clinical experiences with bare balloon expandable
stents to treat JRAAs were analyzed and primary results and
technical considerations for chimney procedure are
presented.
METHODS
Study population
Forty two patients who received Ch-EVAR at the General
Hospital of People’s Liberation Army, Beijing, China from
272 M. XiaoHui et al.January 2008 to June 2013 were included. All patients had
pre-operative computed tomographic angiography (CTA) for
AAA and cardiopulmonary assessment, such as cardiac
ultrasound, chest radiography, and electrocardiogram.
Patients were classiﬁed as high risk if they had serious
cardiovascular and pulmonary comorbidities, and an
American Society of Anesthesiologists (ASA) score of 3 or
more. Four of the patients presented with aortic rupture,
requiring acute intervention. All patients were considered
at high risk for open surgery and were unsuitable (because
of ﬁnancial issues and fear of delays) for FEVAR.
Pre-operative planning was based on CTA with 1.5 mm
slices. The morphology of JRAA included: diameter of
abdominal aortic aneurysm (AAA) 50 mm, diameter of
proximal aneurysmal neck 32 mm, length of proximal
aneurysmal neck <10 mm, and regular, parallel shaped
proximal aneurysmal neck. A proximal landing zone
15 mm in length was required from the superior
mesenteric artery to the proximal aneurysmal neck to
determine the extent of the procedure and the number of
chimney grafts.
Procedure
All procedures were performed in a hybrid operating room
(GE Inova 3100-IQ; General Medical Corporation, USA). All
patients underwent repair under general anesthesia. When
one target artery was involved, left brachial artery percuta-
neous access was obtained. When two target arteries were
involved, access via both brachial arteries was obtained in a
similar fashion. For the bifurcated aortic endograft, in some
cases, both femoral arteries were exposed in the groin
through short transverse incisions; for other cases, percuta-
neous femoral access was obtained with a ProGlide closure
device (Abbott Vascular, Santa Clara, CA, USA).
A 0.035 inch hydrophilic guidewire (Radifocus, Terumo
Medical, Tokyo, Japan) was used to position a multifunction
angiographic catheter above the ostium of renal arteries. ViaFigure 1. The procedures with chimney technique for juxtarenal aortic
chimneys in the right and left renal arteries. (B) The proximal “kissing
looned simultaneously) technique is shown. (C) Completion angiogram
aortic endograft.the brachial access, a 6Fr or 7Fr 90 cm hydrophilic sheath
(Cook Medical, Bloomington, IN, USA) was positioned
approximately 5 cm cranial to the target vessel. Then, all
planned target vessels were cannulated through brachial
sheaths with 0.035 inch Rosen guidewires (Cook Medical,
Bloomington, IN, USA). Before deployment of the main body
of the device, balloon expandable stents were placed in the
designated target vessels as chimneys. The renal stent di-
ameters ranged from 5 to 7 mm. Chimney stents were
deployed 15 mm into the target vessel and were posi-
tioned in the aorta in a manner such that their proximal ends
were positioned 2 to 3 mm above the intended level of the
proximal covered stent of the aortic endograft. If this was not
possible, they were extended with a second, similar diameter
stent. Completion angiography was performed to assess the
patency of the renal arteries and to detect possible endo-
leaks. In the case of type I endoleak, the aortic endograft and
the chimney stents were ballooned simultaneously using a
“kissing balloon” technique (Fig. 1).Postoperative management
After Ch-EVAR, all patients were treated with dual anti-
platelet therapy (clopidogrel 75 mg and aspirin 100 mg
daily) for 6 months. After the 6 months, single antiplatelet
therapy was continued. Patients received hydration therapy
(1000 mL normal saline) in the perioperative 24 hours.
Serum creatinine levels were obtained before, and 3 days
after the operation.Follow up
Follow up included a clinic visit assessing serum creatinine
level and CTA at 3, 6, and 12 months, and annually there-
after. In patients with diminished renal function, non-
contrast CT scan and color ﬂow duplex ultrasound were
used to assess the stent graft, aneurysm size, endoleak, and
the patency of chimney stents.aneurysms (JRAAs). (A) Balloon expandable stents were placed as
balloon” (the aortic endograft and the chimney stents were bal-
showed the patency of chimney stents without endoleak for the
Table 2. Intra-operative data.
Operative time, minutes 184  54 (110e300)
Fluoroscopy time, minutes 38  11 (20e60)
Blood loss, mL 96  122 (50e300)
Contrast dose, mL 251  69 (50e400)
Renal artery stent
Bilateral 14
Right 7
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Continuous data were expressed as mean values  SD.
Categorical variables were described as percentages. Stu-
dent t test was used for independent samples to compare
groups on continuous variables. Statistical analyses were
performed with SPSS (version 20.0 for Windows, SPSS Inc.,
Chicago, IL, USA).Left 21
Renal artery patency, n (%) 56 (100)
LOS after operation, days 7  5 (3e30)
Data given as mean  SD (range), unless otherwise stated.
LOS ¼ length of stay.RESULTS
Demographics
A total of 42 patients (35 males; mean age, 71  7 years)
underwent Ch-EVAR. All patients were considered ineligible
for open repair because of extensive comorbidities. Thirty
ﬁve (83%) patients had an ASA score of 3, and seven (17%)
patients had an ASA score of 4 (Table 1).
On pre-procedural CTA, the mean diameter of AAA was
74  9 mm, and the diameter of the proximal aneurysmal
neck was 25  4 mm. The length of the proximal aneu-
rysmal neck was 7  3 mm, and the angle of the proximal
aneurysmal neck was 57  19.Table 3. Peri-operative and follow up data.
30 day mortality, n (%) 0 (0)
Overall follow up mortality 2 (5)
Complication
Renal stent occlusion 1 (2)
Acute renal failure 2 (5)
Stroke 1 (2)
Endoleak
Completion angiogram
Type Ⅰ 8 (19)
6 monthIntra-operative management
The data for all patients are reported in Table 3. Operative
time was 184  54 minutes, while ﬂuoroscopy time was
38  11 minutes. Blood loss was 96  122 mL, 251  69 mL
of contrast was used, and the length of stay after operation
was 7  5 days.
The endografts employed were 13 Zenith (Cook Medical,
Bloomington, IN, USA), 27 Endurant, and two Talent
(Medtronic Inc., Sunrise, FL, USA). Seventy BESs were used
for 56 target renal arteries, including 59 Hippocampus
(Invatec Inc., Roncadelle, Medtronic) and 11 Genesis
(Johnson & Johnson Medical, Ltd.). Fourteen patients had
bilateral renal revascularization, seven patients underwent
single left renal artery chimney, and 21 patients received
right renal artery chimney only. For chimney stent, the di-
ameters ranged from 5 to 7 mm and the lengths were be-
tween 20 and 80 mm, which included the sum of lengthsTable 1. Demographic data.
Age, mean  SD 71  7
Male, N (%) 35 (83)
Comorbidities, N (%)
Hypertension 39 (93)
COPD 23 (55)
PCE 12 (29)
PAD 10 (24)
CRI 7 (17)
Diabetes 13 (31)
Arrhythmia 9 (21)
CAD 32 (76)
MI 11 (26)
COPD ¼ chronic obstructive pulmonary disease; CAD ¼ Coronary
artery disease; PCE ¼ Previous cerebrovascular event; PAD ¼
Peripheral arterial disease; CRI ¼ chronic renal insufﬁciency;
MI ¼ myocardial infarction.with two overlapped chimney stents (7 cases). More
detailed technical descriptions are listed in Table 2.
In this study, all chimney procedures were successful,
without any renal arteries sacriﬁced. Primary technical
success was 100%, with adequate cannulation and place-
ment of all target vessels and exclusion of the aneurysm.Endoleak
After complete deployment of the chimney stents and
endografts, the intra-operative angiogram showed that 13
patients (31%) had type Ia endoleak. Five cases were solved
using the proximal “kissing balloon” technique, and eight
other cases (19%) showed a persistent leak on the ﬁnal
angiogram which it was decided did not need to be treated
immediately. The 6 month CTA showed three cases with
complete regression of endoleak (Fig. 2), two cases withoutType Ⅰ 5 (12)
Type Ⅱ 2 (5)
The latest follow up
Type Ⅰ 5 (12)
Renal function
Pre-operation
CRI 6 (14)
Creatinine (mmol/L) 88  50
Post-operation
Creatinine (mmol/L)
3 days 91  52
3 months 101  52
The latest follow up 112  52
CIN 3 (7)
Renal failure 2 (5)
Dialysis dependent renal failure 2 (5)
Data given as mean  SD, or n (%).
CRI ¼ chronic renal insufﬁciency; CIN ¼ contrast induced
nephropathy.
Figure 2. In this patient, a persistent type I endoleak was noted in
the proximal neck on the ﬁnal angiogram. Six month follow up CTA
showed that the type I endoleak regressed completely. The
aneurysm diameter remained stable, and the chimney stent
retained patency.
274 M. XiaoHui et al.aneurysmal growth, and three cases with an increase in the
diameter of aneurysm of less than 10mm. In view of the poor
physical condition of these patients, a conservative policy
with strict radiologic surveillance was adopted (Table 3).
Renal function
According to the deﬁnition of contrast induced nephropathy
(CIN),5 three patients suffered from CIN. Two had acute
renal failure (ARF), respectively, 3 days and 4 days after the
procedure. Their creatinine levels increased to three times
pre-operative levels, and their post-operative urine volumes
decreased signiﬁcantly. Both patients required permanent
hemodialysis. In the third patient, the post-operative
creatinine level increased 60 mmol/L compared with pre-
operative level, but urine volume was normal. The pa-
tient’s creatinine level decreased and stabilized at the pre-
operative level 10 days after the operation. Complete oc-
clusion of one right renal artery was seen on the 3 month
follow up CTA, but the most recent renal function test was
normal, because the left renal artery compensated.
Follow up
Patients were discharged 10 days (range 5e28 days) after Ch-
EVAR.Median followupwas 26months (range 6e64months),
during which there were two deaths unrelated to the aorta: a
hemispheric stroke 6 months and respiratory failure 12
months after the procedure respectively.Therefore, the overall
follow up mortality was 5%. The 30 day mortality and overall
follow up mortality are shown in Table 3.
Follow up CT and duplex scans showed the patency of all
renal arteries, except one chimney stent, which occluded 3
months after discharge, so the follow up patency rate of
chimney stents was 98%. The aneurysm diameter reduced
from 74  9 mm to 64  10 mm during follow up (p < .05),
but in three cases there was an increase in aneurysm
diameter of less than 10 mm because of type Ia endoleak.
In 24 patients, the aneurysm diameter decreased more than
5 mm. The aneurysm diameter remained stable in the other15 patients. There was only one case (2%) of stroke (with
bilateral brachial approach) 1 day after procedure; the pa-
tient recovered smoothly during follow up.DISCUSSION
First described in 2003 by Greenberg6 in the setting of patients
with challenging proximal neck, Ch-EVAR was advocated as a
valid option for the treatment of JRAAs. Recent improvements
of FEVARhave demonstrated promising results,7 but the use of
such devices mandates highly precise planning, a
manufacturing delay of 3 months, and a signiﬁcant cost
because each device is customized for each patient’s anatomy.
In China the cost of FEVAR is about $50000, whereas Ch-EVAR
costs less than $30000. According to policy, patients need to
pledge about $40,000 individually upfront for FEVAR, but
many do not have enough money. Moreover, devices for
FEVAR are not yet commercially available in China. Therefore,
FEVAR is limited to a few investigational centers.
In this study, although the technical success rate was 100%
and the 30 daymortality was 0%, and for most patients (93%)
their aneurysms become stable or shrank during follow up,
which is in line with previous published results,8e12 it was
important to remain aware of the higher incidence of type I
endoleak after the procedure. Eligible patients for Ch-EVAR
should be selected carefully. The success of chimney pro-
cedures depends on suitable anatomical conditions, careful
pre-operative assessment, and the experience of the oper-
ator.11 Compared with previous reports, the present study
had a larger population and longer duration of follow up and
furthermore, there was a better insight into the applicability
of the chimney technique with BES for JRAAs.
Covered, uncovered, balloon, and self-expandable stents
have different mechanisms of action. Uncovered stents
generate a ﬂow channel between the stent graft and aortic
wall to maintain vascularization, where covered stents carry
the blood directly to the target vessel. Many authors suggest
that covered stents are beneﬁcial because pressurization of
the peri-graft channels is reduced, lowering the chance of type
I endoleak, and also that they have longer term patency than
uncovered stents.8,13,14 However, other authors suggest that
the covered nature of the stent does not confer any advantage
in renal patency or any protection against type I endoleak.9,15
The opinion of the present authors is that, although a covered
stent is recommended by more current documents, an un-
covered stent may allows a higher renal blood ﬂow through
the “physiological” channel,12 and that uncovered stents are
implanted easily into the renal arteries because of their ﬂexi-
bility. Moreover, no suitable covered stents are commercially
available in China, so uncovered stents are inevitably the
choice of the present authors. Regarding select balloon or self
expandable stents, Lee11 states that deployment and angio-
plasty of BES can be performed in one maneuver, so opera-
tional efﬁciency can be improved with no need to change the
guide wire and release system. Therefore, the present authors
prefer BES for chimney procedures.
The main problem with Ch-EVAR is whether a proximal
seal can be safely achieved. The “gaps” located between the
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origin of endoleak. In theory, the occurrence of type I
endoleak is related to the number and the size of chimney
stents.4 According to results from previous studies, the type
I endoleak rate was up to 19%, which was higher than other
studies.16e18 This was particularly high for JRAAs with
tortuous aneurysm necks; of 15 cases with tortuous neck
(mean angle, 76  8), seven (47%) presented with a type I
endoleak on the completion angiogram. Although no sta-
tistically signiﬁcant difference could be detected among the
groups, a tendency toward increased rate of type I endoleak
proportional to the angle of aneurysm neck and the number
of chimney grafts was observed. It is suggested that an
angle under 60 and employment of fewer than 2 chimney
grafts are likely to be the optimum conditions without
compromising the proximal seal.
To date, how best to judge the degree of type I endoleak
has not been deﬁned. This could be done by comparing the
intensity and speed of ﬂow of the contrast agent into the
aneurysm cavity and main body of stent graft. If these are
the same, the endoleak is judged to be large. If the speed of
ﬂow into the aneurysmal cavity is signiﬁcantly slower than
into the main body of stent graft, and the opacity in
aneurysmal cavity is signiﬁcantly less than in the main body
of stent graft, the endoleak could be judged to be mild, with
a moderate endoleak falling between the two. However, it
was recognized gradually that for some patients, especially
those with serious tortuous neck, different degrees of
endoleak would be observed after Ch-EVAR. Although the 6
month follow up CTA showed three cases with complete
regression of endoleak, some endoleaks may disappear at
the early stage after EVAR. The reasons for this included
correction of coagulation abnormalities, and the self
expanding nature of the stentgrafts leading to gradual neck
remodeling and improved graft wall apposition.17,18
Almost all currently available stent grafts can only treat
JRAAs with proximal landing zones of 10 mm length, but
the 10 mm threshold for Endurant (Medtronic Inc., Sunrise,
FL, USA) has been proved to be quite safe.19 While the
Ovation device (TriVascular Inc., Santa Rosa, CA) is the only
stent graft approved to treat proximal necks shorter than
10 mm (7 mm), the Nellix system (Endologix Inc., Sunrise,
FL, USA) is an investigational device that can successfully
treat proximal necks as short as 5 mm. Other new devices
such as EndoAnchors (Aptus Endosystems, Sunnyvale, CA,
USA) can treat existing and acute type Ia endoleaks and
endograft migration successfully in most cases. Prophylactic
use of EndoAnchors in patients with hostile aortic neck
anatomy has also yielded promising results.20CONCLUSION
In this retrospective report, the technical aspects and pri-
mary results from 42 patients who received the chimney
technique are presented. Until standardized fenestrated
and branched stent grafts or other new devices become
widely available, Ch-EVAR offers a cheaper and immediately
available technique for the treatment of JRAAs with suitableanatomy. However, the higher probability of proximal type I
endoleak with chimney stents must be noted, so further
studies are needed to prove its efﬁciency.CONFLICT OF INTEREST
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